Is a complete NERV research report available?

No complete published report is available for Minerva Neurosciences, Inc. (NERV) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Minerva Neurosciences, Inc. (NERV)

NASDAQ: NERV · USD

$4.45

+0.02 (+0.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first NERV analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	207.3M
Net income (ttm)	-415.1M
EPS (ttm)	-$23.7
Shares out	46.6M
Volume	135,631
Beta	-0.18
Price target	$9.50	+113.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -415.1M
EPS (ttm): -$23.7
Market cap: 207.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All NERV indicators

Market & fundamental data

Available fields

175

Groups with data

Currency

USD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001598646
Company name	Minerva Neurosciences, Inc.
Country	United States
Country code	US
Cusip	603380205
Employees	7
Employees Change	-1%
Employees Change Percent	-12.5
Enterprise value	$189.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2014-07-01
Isin	US6033802058
Last refreshed	2026-07-24
Market cap	$207.3M
Market cap category	Micro-Cap
Price	$4.45
Price currency	USD
Sector	Healthcare
Sector PE	44.54
Sector PE Fwd	23.46
Sic	2834
Symbol	NERV
Website	https://www.minervaneurosciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-200.21%
FCF yield	-7.17%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-9.7M
Net Income	$-415.1M
Net Income Growth Years	0%
Profit Per Employee	$-59.3M
ROA	-27.47
Roa5y	-24.13
ROCE	-31.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-25.65%
Cagr1y	124.87%
Cagr3y	-19.15%
Cagr5y	-22.58%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$94M
Cash	$78.1M
Current Assets	$79.1M
Current Liabilities	$4.5M
Debt	$60M
Equity	$-249.1M
Liabilities	$343.1M
Long Term Assets	$14.9M
Long Term Liabilities	$338.6M
Net Cash	$18.1M
Net Cash By Market Cap	$8.71
Tangible Book Value	$-268.9M
Tangible Book Value Per Share	$-6.13
WACC	2.53

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	17.65
Net Working Capital	$-3.4M
Quick ratio	17.42
Working Capital	$74.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-131.67%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-94.84%
1Y total return	124.75%
200-day SMA	4.95
3Y total return	-47.15%
50-day SMA	4.74
50-day SMA vs 200-day SMA	50under200
5Y total return	-72.19%
All Time High	126.7
All Time High Change	-96.49%
All Time High Date	2016-06-02
All Time Low	1.15
All Time Low Change	286.96%
All Time Low Date	2025-04-09
ATR	0.42
Beta	-0.18
Beta1y	1.71
Beta2y	1.21
Ch YTD	10.7
High	4.68
High52	12.46
High52 Date	2025-10-21
High52ch	-64.29%
Low	4.27
Low52	1.76
Low52 Date	2025-08-13
Low52ch	152.84%
Ma50ch	-6.18%
Price vs 200-day SMA	-10.12%
RSI	46.67
RSI Monthly	49.89
RSI Weekly	45.19
Sharpe ratio	1.02x
Sortino ratio	3.15
Total Return	-131.67%
Tr YTD	10.7
Tr1m	-4.51%
Tr1w	5.7%
Tr3m	-39.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	2
Analyst Price Target Top	$10.5
Analyst Ratings	Hold
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.01
Operating Income	$-27.9M
Price target	$9.5
Price Target Change	$113
Price Target Change Top	$136

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	30,870,973%
Float Percent	66.26%
Shares Insiders	0.6%
Shares Institutions	66.79%
Shares Out	46,588,709
Shares Qo Q	294.86%
Shares Yo Y	131.67%
Short Float	6.17%
Short Ratio	5.59
Short Shares	4.09

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-24.6M
Average Volume	378,075.6x
Bv Per Share	-5.79
Ch10y	-94.84
Ch1m	-4.51
Ch1w	5.7
Ch1y	124.7
Ch3m	-39.46
Ch3y	-47.15
Ch5y	-72.19
Ch6m	14.1
Change	0.45%
Change From Open	2.53
Close	4.43
Days Gap	-2.03
Depreciation Amortization	5,442
Dollar Volume	603,558
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-27.9M
EBITDA	$-27.9M
EPS	$-23.66
F Score	2
FCF	$-14.9M
FCF EV Yield	-7.86x
FCF Per Share	$-0.32
Financing CF	75,529,866
Fiscal Year End	December
Founded	2,007
Goodwill	14,869,399
Investing CF	-45,294,104
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Date	2022-06-21
Last Split Type	Reverse
Last10k Filing Date	2026-03-11
Ma150	5.36
Ma150ch	-16.9%
Ma20	4.61
Ma20ch	-3.55%
Net CF	15,369,722
Next Earnings Date	2026-08-13
Open	4.34
Optionable	No
Position In Range	43.9
Post Close	4.45
Postmarket Change Percent	1.8
Postmarket Price	$4.53
Price Date	2026-07-23
Relative Volume	0.36x
Share Based Comp	9,740,445
Tr6m	14.1%
Us State	Massachusetts
Volume	135,631

Minerva Neurosciences, Inc. (NERV)

Coverage state: Market snapshot only — no published research

Generate the first NERV analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · NERV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NERV indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NERV

Frequently asked questions